ARW-10085-45579
4 vaccinations
10 coded responses
42 check-ins
10 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 460 / IN
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-02-17
Registered in v-safe
-
2021-02-22
Dose 2 — Pfizer-BioNTech
- 2021-02-22
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-02-24
- 2021-02-25
- 2021-02-27
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-24
- 2021-03-29
- 2021-04-05
- 2021-05-24
-
2021-08-23
Survey response — 6 months, dose 2MedDRA: Blood glucose increased, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: pre-appointment blood test indicated high glucose · Healthcare visit (other): standard pre-set mid year physicalMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-23
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-01
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-05
Survey response — day 0, dose 3MedDRA: Arthralgia, Pain — Feeling: GoodFree text: normal joint and body achesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2022-01-04
- 2022-04-06
-
2022-07-21
Dose 4 — Pfizer-BioNTech
- 2022-07-21
-
2022-07-23
Survey response — days 1–6 daily, dose 4MedDRA: Nausea — Feeling: Good · NauseaFree text: nausea not related to vaccineMedDRA releases: 2024-11 · check-in free text available
-
2022-07-24
Survey response — days 1–6 daily, dose 4MedDRA: Gastrointestinal disorder — Feeling: PoorFree text: digestive issues not related to the vaccineMedDRA releases: 2024-11 · check-in free text available
-
2022-07-25
Survey response — days 1–6 daily, dose 4MedDRA: Gastrointestinal disorder — Feeling: FairFree text: as said the previous non-related digestive issues continueMedDRA releases: 2024-11 · check-in free text available
-
2022-07-26
Survey response — days 1–6 daily, dose 4MedDRA: Pre-existing disease — Feeling: FairFree text: non-related to vaccine digestive issues continueMedDRA releases: 2024-11 · check-in free text available
-
2022-07-27
Survey response — days 1–6 daily, dose 4MedDRA: Gastrointestinal disorder — Feeling: FairFree text: non-related to vaccine digestive issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-07-28
Survey response — day 7, dose 4MedDRA: Pre-existing disease — Feeling: FairFree text: non-related to vaccine digestive issues continueMedDRA releases: 2024-11 · check-in free text available
- 2022-08-04
-
2022-08-11
Survey response — day 21, dose 4MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: developed other non-vaccine health issues · Healthcare visit (other): oncology treatmentMedDRA releases: 2024-11 · check-in free text available
-
2022-08-11
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-08-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-08-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-08-18
Survey response — day 28, dose 4MedDRA: Pre-existing disease — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: pancreatic cancer treatmentMedDRA releases: 2024-11 · check-in free text available
-
2022-08-18
Report sent to call center — day 28, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-08-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-25
- 2022-09-01
- 2022-10-20
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-07-21 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: pre-appointment blood test indicated high glucose
Healthcare visit (other): standard pre-set mid year physical
Release 10 — day 0, dose 3
Systemic reaction (other): normal joint and body aches
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): nausea not related to vaccine
Systemic reaction (other): digestive issues not related to the vaccine
Systemic reaction (other): as said the previous non-related digestive issues continue
Systemic reaction (other): non-related to vaccine digestive issues continue
Systemic reaction (other): non-related to vaccine digestive issues
Release 12 — day 7, dose 4
Systemic reaction (other): non-related to vaccine digestive issues continue
Release 12 — day 21, dose 4
Symptoms: developed other non-vaccine health issues
Healthcare visit (other): oncology treatment
Release 12 — day 28, dose 4
Symptoms: pancreatic cancer treatment
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Blood glucose increased | ✓ | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Gastrointestinal disorder | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release